Clinical Trials

NCT06745804 | COMPLETED | PHASE1
27 participants

Study of 68Ga-R10602

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2024-12-10
Completion:
2026-05-04
Conditions
  • Locoregionally Recurrent Hormone-receptor Positive Breast Cancer
  • Metastatic Hormone Receptor Positive Breast Cancer
  • Hormone Receptor Positive Breast Adenocarcinoma
Interventions
  • DRUG
No Results Yet
NCT06712394 | COMPLETED
84 participants

Knee Osteoarthritis and IPACK

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-06
Start Date:
2025-01-02
Completion:
2026-05-15
Conditions
  • Osteoarthritis, Knee
Interventions
  • PROCEDURE
No Results Yet
NCT06710756 | RECRUITING | PHASE1/PHASE2
112 participants

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2025-04-28
Completion:
2028-01-31
Conditions
  • Pancreatic Ductal Adenocarcinoma
  • Gastric Cancer
  • Esophageal Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Head and Neck Cancer
  • Sarcoma
  • Mesothelioma
Interventions
  • DRUG
No Results Yet
NCT06694740 | RECRUITING | PHASE2/PHASE3
170 participants

Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2026-02-24
Completion:
2029-03-31
Conditions
  • Post-aggressive Immunosuppression
  • Adult Patients Admitted to Intensive Care With Initial Severity (SOFA of the First 24 Hours Post-admission ≥ 6
  • Adult Under Mechanical Ventilation, and Presenting an mHLA-DR Less Than 8,000AB/C
Interventions
  • DRUG
No Results Yet
NCT06535607 | RECRUITING | PHASE2
257 participants

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-06
Start Date:
2024-08-22
Completion:
2028-11-30
Conditions
  • Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)
  • Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)
  • Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
  • Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
  • Sub-study 5 Unresectable Pleural Mesothelioma (Volrustomig Monotherapy)
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page